| | | | | |
| €27,4267 | +0,73% | €240,47M | €7,08K | |
DBL DOUBLELINE OPPORTUNISTIC CREDIT FUND | €12,0836 | +0,04% | €240,18M | €8,96K | |
TSI TCW Strategic Income Fund, Inc. | €3,7507 | +0,34% | €239,79M | €46,13K | |
PAII Pyrophyte Acquisition Corp. II | €8,8002 | +0,05% | €239,36M | €18,00 | |
| €11,8736 | -5,33% | €239,25M | €166,29K | |
YDES YD Bio Limited Ordinary Shares | €3,9864 | -0,85% | €239,25M | €6,08K | |
XCBE X3 Acquisition Corp. Ltd. Class A Ordinary Shares | €8,5679 | +0,04% | €238,94M | €13,71 | |
RWAY Runway Growth Finance Corp. Common Stock | €5,6367 | -0,98% | €238,93M | €123,44K | |
JILL J.Jill, Inc. Common Stock | €17,7538 | +2,47% | €238,92M | €13,43K | |
LCTX Lineage Cell Therapeutics, Inc. | €0,93874 | +1,39% | €238,49M | €291,01K | |
AXIN Axiom Intelligence Acquisition Corp 1 Class A Ordinary Shares | €8,8482 | +0,11% | €238,43M | €10,61K | |
ACV Virtus Diversified Income & Convertible Fund | €22,8556 | +0,04% | €238,40M | €1,64K | |
ALXO ALX Oncology Holdings Inc. Common Stock | €1,7017 | -2,70% | €238,27M | €91,49K | |
| €1,2045 | -1,75% | €238,18M | €101,09K | |
YSG Yatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares | €2,5848 | +0,50% | €238,04M | €22,38K | |
